Loading...

Notice

Check the various announcements of oncoMASTER.

[oncoMASTER Director press release] “Cancer precision medicine platform oncoMASTER CEO Kim Yeol-hong” (2022. 08. 01. Medical Times Meta Lounge)

2024.02.07 14:37

[oncoMASTER Director press release] “Cancer precision medicine platform oncoMASTER CEO Kim Yeol-hong” (2022. 08. 01. Medical Times Meta Lounge)

“Cancer precision medicine platform oncoMASTER CEO Kim Yeol-hong”

[Interview] Kim Yeol-hong, Professor of Oncology at Korea University

What is the medical service CEO Kim dreams of through the cancer precision medicine platform?

 

link

https://www.medicaltimes.com/Main/News/NewsView.html?ID=1148679

Source: Medical Times Meta Lounge (Reporter Youngho Moon_2022. 08. 01)


ONCOCROSS Co., Ltd.

Business registration number: 482-86-00109 | CEO: Yi Rang KIM / Jihoon KANG

Address: Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)

Email: oncocross@oncocross.com

ⓒ ONCOCROSS CO., LTD. All Rights Reserved.

온코마스터 로고.